Javanbakht MH - Search Results

1

Effects of imatinib mesylate in mouse models of multiple sclerosis and in vitro determinants.

Azizi G, Haidari MR, Khorramizadeh M, Naddafi F, Sadria R, Javanbakht MH, Sedaghat R, Tofighi Zavareh F, Mirshafiey A. Azizi G, et al. Among authors: javanbakht mh. Iran J Allergy Asthma Immunol. 2014 Jun;13(3):198-206. Iran J Allergy Asthma Immunol. 2014. PMID: 24659124 Free article.

2

Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis.

Javanbakht MH, Keshavarz SA, Djalali M, Siassi F, Eshraghian MR, Firooz A, Seirafi H, Ehsani AH, Chamari M, Mirshafiey A. Javanbakht MH, et al. J Dermatolog Treat. 2011 Jun;22(3):144-50. doi: 10.3109/09546630903578566. Epub 2010 Jul 24. J Dermatolog Treat. 2011. PMID: 20653487 Free article. Clinical Trial.

3

Soy protein and genistein improves renal antioxidant status in experimental nephrotic syndrome.

Javanbakht MH, Sadria R, Djalali M, Derakhshanian H, Hosseinzadeh P, Zarei M, Azizi G, Sedaghat R, Mirshafiey A. Javanbakht MH, et al. Nefrologia. 2014;34(4):483-90. doi: 10.3265/Nefrologia.pre2014.Jun.12051. Nefrologia. 2014. PMID: 25036062 Free article. English, Spanish.

4

Effect of Genistein and L-Carnitine and Their Combination on Gene Expression of Hepatocyte HMG-COA Reductase and LDL Receptor in Experimental Nephrotic Syndrome.

Yousefinejad A, Siassi F, Mirshafiey A, Eshraghian MR, Koohdani F, Javanbakht MH, Sedaghat R, Ramezani A, Zarei M, Djalali M. Yousefinejad A, et al. Among authors: javanbakht mh. Iran J Public Health. 2015 Oct;44(10):1339-47. Iran J Public Health. 2015. PMID: 26576346 Free PMC article.

5

Cardioprotective effect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model.

Mortazavi-Jahromi SS, Alizadeh S, Javanbakht MH, Mirshafiey A. Mortazavi-Jahromi SS, et al. Among authors: javanbakht mh. Immunopharmacol Immunotoxicol. 2018 Aug;40(4):284-289. doi: 10.1080/08923973.2018.1455209. Epub 2018 Apr 5. Immunopharmacol Immunotoxicol. 2018. PMID: 29619884

6

Vitamin D3 Induces Gene Expression of Ox-LDL Scavenger Receptors in Streptozotocin-Induced Diabetic Rat Aortas: New Insight into the Role of Vitamin D in Diabetic Atherosclerosis.

Alizadeh S, Mirshafiey A, Djalali M, Alvandi E, Mohammadzadeh Honarvar N, Javanbakht MH. Alizadeh S, et al. Among authors: javanbakht mh. Rep Biochem Mol Biol. 2018 Apr;6(2):170-177. Rep Biochem Mol Biol. 2018. PMID: 29766000 Free PMC article.

7

Anti-diabetic effect of β-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property on insulin production, blood glucose, and inflammatory markers in the experimental diabetes model.

Mortazavi-Jahromi SS, Alizadeh S, Javanbakht MH, Mirshafiey A. Mortazavi-Jahromi SS, et al. Among authors: javanbakht mh. Arch Physiol Biochem. 2019 Dec;125(5):435-440. doi: 10.1080/13813455.2018.1481094. Epub 2018 Jun 8. Arch Physiol Biochem. 2019. PMID: 29882437

8

The Effect of Vitamin D on Cellular Pathways of Diabetic Nephropathy.

Derakhshanian H, Djazayery A, Javanbakht MH, Eshraghian MR, Mirshafiey A, Zarei M, Alvandi E, Djalali E, Djalali M. Derakhshanian H, et al. Among authors: javanbakht mh. Rep Biochem Mol Biol. 2019 Jan;7(2):217-222. Rep Biochem Mol Biol. 2019. PMID: 30805403 Free PMC article.

9

Vitamin D downregulates key genes of diabetes complications in cardiomyocyte.

Derakhshanian H, Djazayery A, Javanbakht MH, Eshraghian MR, Mirshafiey A, Jahanabadi S, Ghadbeigi S, Zarei M, Alvandi E, Djalali M. Derakhshanian H, et al. Among authors: javanbakht mh. J Cell Physiol. 2019 Nov;234(11):21352-21358. doi: 10.1002/jcp.28743. Epub 2019 Jun 7. J Cell Physiol. 2019. PMID: 31173353

10

Anti-Diabetic and Angio-Protective Effect of Guluronic Acid (G2013) as a New Nonsteroidal Anti-Inflammatory Drug in the Experimental Model of Diabetes.

Mortazavi-Jahromi SS, Alizadeh S, Javanbakht MH, Mirshafiey A. Mortazavi-Jahromi SS, et al. Among authors: javanbakht mh. Endocr Metab Immune Disord Drug Targets. 2020;20(3):446-452. doi: 10.2174/1871530319666191016103918. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31622213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters